Vol. 3 No. 3-S2 (2009): CUAJ June-Suppl 2

Afficher Vol. 3 No. 3-S2 (2009): CUAJ June-Suppl 2

Publié-e: 2013-05-01

Supplement-Introduction

Sharing the responsibility of prostate cancer risk reduction

Laurence Klotz, Yves Fradet, Larry Goldenberg, Simon Tanguay

S91
- PDF (English)

Review

Diagnosis and management of benign prostatic hyperplasia in primary care

Simon Tanguay, Murray Awde, Gerald Brock, Richard Casey, Joseph Kozak, Jay Lee, J. Curtis Nickel, Fred Saad

S92-S100
- PDF (English)
The burden of prostate cancer in Canada

Yves Fradet, Laurence Klotz, John Trachtenberg, Alexandre Zlotta

S102-S108
- PDF (English)
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?

Larry Goldenberg, Alan So, Neil Fleshner, Ricardo Rendon, Darrel Drachenberg, Mostafa Elhilali

S109-S114
- PDF (English)
Gleason grading controversies: what the chemoprevention trials have taught us

Laurence Klotz, Darrel Drachenberg, Yves Fradet, Fred Saad, John Trachtenberg, Alexandre Zlotta

S115-S120
- PDF (English)